迪哲医药: 迪哲医药：首次公开发行部分限售股上市流通公告

Core Viewpoint - The announcement details the upcoming listing and circulation of restricted shares for Dize Pharmaceutical Co., Ltd., with a total of 223,013,329 shares set to be released on July 1, 2025, representing 48.54% of the company's total share capital [1][3][13]. Summary by Sections Listing of Restricted Shares - The type of shares being listed is restricted shares from the company's initial public offering (IPO) [2]. - The total number of shares to be listed is 223,013,329, which will be available for trading starting July 1, 2025 [1][6]. Shareholder Commitments - Major shareholders, including Advanced Manufacturing Industry Investment Fund and AstraZeneca AB, are required to adhere to specific commitments regarding share lock-up and reduction [2][3]. - The first major shareholder, Advanced Manufacturing, and AstraZeneca AB are prohibited from reducing their holdings through trading until certain conditions are met, particularly if the company has not paid cash dividends due to losses [2][3]. Changes in Share Capital - The company's total share capital has increased from 400,000,100 shares to 459,412,894 shares due to various stock option plans and incentive programs [4][5]. - The increase includes 12,103,020 shares from the 2020 employee stock option plan and additional shares from the 2022 restricted stock incentive plan [4][5]. Commitments from Major Shareholders - Advanced Manufacturing and AstraZeneca AB have committed not to transfer or manage their shares for 36 months following the company's IPO [8][10]. - If the company does not achieve profitability, these shareholders cannot reduce their holdings for three full accounting years after the IPO [8][10]. Verification by Intermediaries - The underwriting institution, Huatai United Securities, has confirmed that all commitments related to the restricted shares have been strictly adhered to by the shareholders [11]. - The verification indicates that the listing of restricted shares complies with relevant laws and regulations [11]. Details of Restricted Shares - The total number of restricted shares being listed is 223,013,329, which will be available for trading on July 1, 2025 [6][13]. - The shareholders holding these restricted shares include Advanced Manufacturing, AstraZeneca AB, and ZYTZ Partners Limited [3][13].